Indegene Limited , a prominent player in the Indian healthcare technology sector, has announced a significant change in its board composition. Mr. Neeraj Bharadwaj has stepped down from his role as Non-Executive, Non-Independent Director of the company, effective immediately.

Resignation Details

The resignation, disclosed in a regulatory filing to the BSE and NSE, comes in the wake of CA Dawn Investments' exit from Indegene Limited. Mr. Bharadwaj had been representing CA Dawn Investments on the company's board.

In his resignation letter, Mr. Bharadwaj expressed his gratitude to the board and management of Indegene Limited for their support during his tenure. He also conveyed his best wishes for the company's continued success and growth in the future.

Regulatory Compliance

Indegene Limited, in compliance with Regulation 30 of the Securities and Exchange Board of India (SEBI) Listing Obligations and Disclosure Requirements Regulations, 2015, promptly informed the stock exchanges about this development. The company provided the necessary disclosures, including the reason for the change and the effective date of cessation.

Company Response

Srishti Ramesh Kaushik, Company Secretary and Compliance Officer of Indegene Limited, confirmed that the information regarding Mr. Bharadwaj's resignation would be made available on the company's official website.

About Indegene Limited

Indegene Limited is headquartered in Bengaluru, Karnataka. The company operates in the healthcare technology sector, providing a range of services to global healthcare and life sciences organizations.

This board-level change comes at a time when the healthcare technology sector is experiencing rapid growth and transformation. Stakeholders will be keen to observe how this development might influence Indegene's strategic direction in the coming months.

Indegene , a digital-first life sciences commercialization company, has announced the launch of NEXT Medical Writing Automation, an advanced platform that combines deep medical writing expertise with generative AI (GenAI) technology. This innovative tool aims to streamline complex medical writing workflows across clinical development, regulatory submissions, and beyond.

Revolutionizing Medical Writing

NEXT Medical Writing Automation is designed to address the challenges faced by medical writing teams, who are often under pressure to deliver precise, regulatory-ready documents within tight deadlines. The platform operates within familiar environments like Microsoft Word, auto-generating compliant drafts that adapt to diverse sponsor formats and workflows.

Key Features and Benefits

• Integration with Existing Systems: NEXT seamlessly integrates with Regulatory Information Management (RIM) systems, maintaining traceability and consistency across documents.
• Efficiency Boost: The platform offers automated scheduling, intelligent task assignments, and robust data flow integration, helping life sciences organizations scale operations efficiently.
• Compliance Focus: While enhancing efficiency, NEXT maintains a strong compliance backbone, crucial in an environment of growing document requirements and increased scrutiny.

Leveraging Cortex AI Engine

At the heart of NEXT is Indegene's Cortex AI engine, a life sciences-specialist knowledge engineering and multi-agent orchestration platform. Cortex enables life sciences leaders to adopt and scale this transformative technology with enterprise-grade governance.

Industry Impact

Sameer Lal, SVP, Enterprise Medical Solutions at Indegene, commented on the launch: "We see this platform as more than automation—it's about elevating the entire practice of medical writing. Writers can now focus on strategic tasks and critical thinking, while the platform manages the heavy lift of data and formatting."

About Indegene

Indegene Limited is a digital-first, life sciences commercialization company. It helps biopharmaceutical, emerging biotech, and medical device companies develop products, get them to market, and grow their impact through the life cycle in a more effective, efficient, and modern way.

The launch of NEXT Medical Writing Automation reinforces Indegene's commitment to building AI-driven, domain-first solutions that help life sciences organizations modernize critical processes and meet business objectives with confidence.

For more information about Indegene and its services, visit www.indegene.com .